XBiotech Inc. (XBIT)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $2.16
- As of
Kresmion compiles this page from XBIT's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
XBiotech Inc. (XBIT): 3 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-08-13.
See the full XBIT dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for XBIT on one page. Preview it with sample data, then open it live with a free account.
Preview the XBIT dossierActive signals for XBIT
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +59% to XBIT (2026Q2)
- highINSTITUTIONAL_SURGE
RENAISSANCE TECHNOLOGIES LLC added +86% to XBIT (2026Q2)
- mediumNEW_POSITION
RENAISSANCE TECHNOLOGIES LLC new position in XBIT
- mediumEARNINGS_BEAT
Q4-2019: Beat consensus by 9635.9% - EPS $14.59 vs $-0.153 estimate
- mediumEARNINGS_BEAT
Beat consensus by 9635.9% - EPS $14.59 vs $-0.153 estimate
FREE, NO ACCOUNT
Every signal on XBIT, as it fires
You are seeing 5 of 6 signals recorded on XBIT since 2026-05-26.
The five above landed across 4 days. The other 1 were recorded on those same days. 3 of the 6 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in XBIT (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLCCUSIP 98400H102 · 2026Q2 | $182K | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 98400H102 · 2026Q2 | $96K | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 98400H102 · 2026Q2 | $67K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, XBIT
- 10-QSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
XBIT against its peers
XBIT's return on equity of -32.4% ranks in the 72nd percentile of 15 Biotechnology sub-industry peers, fiscal periods ending between 2025-06-30 and 2026-04-30.
| Metric | XBIT | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | n/a | 7.9M | n/a | 12 |
| Operating margin | n/a | -93.5% | n/a | 10 |
| Net margin | n/a | -75.8% | n/a | 11 |
| Return on equity | -32.4% | -108.6% | 72 | 15 |
| 1 year | -15.6% | -27.4% | 73 | 19 |
Peers (22): NMRA, RNTX, CSBR, CING, HRTX, FBIO, MAIA, RNXT, GANX, SPRO, MNOV, VRCA, OSTX, KLRS, NTHI, INKT, KZIA, PTHS, ELOX, ACET, ONCY, AURX. Left out: HYFT (period gap), APLM (period gap), OKYO (period gap). Fiscal periods ending between 2025-06-30 and 2026-04-30. Every figure is one full fiscal year read from one annual filing (XBIT: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow XBIT on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to XBIT for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.